Azafaros is developing new treatment options to help patients with rare metabolic disorders. Azafaros was founded in 2018 by a team of experienced industry professionals and scientists aspiring to address rare genetic metabolic disorders through a pipeline of oral small molecules with disease-modifying potential. 

Biotechnology

Azafaros

The Basel office focuses on advanced drug development and clinical trial management, ensuring high quality and compliance.

Basel

Azafaros' headquarters in Naarden, Netherlands

People (4)

Jobs (0)

Other offices